{"disease":{"id":"choroidal-melanoma","name":"choroidal melanoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02875652","title":"Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)","phase":"NA","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT06007690","title":"A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Aura Biosciences","has_results":false},{"nct_id":"NCT07338968","title":"A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Aura Biosciences","has_results":false},{"nct_id":"NCT00344799","title":"Cytogenetic Study of Ocular Melanoma","phase":"","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03052127","title":"Study in Subjects With Small Primary Choroidal Melanoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Aura Biosciences","has_results":true},{"nct_id":"NCT04728633","title":"Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT04417530","title":"Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Aura Biosciences","has_results":false},{"nct_id":"NCT07421739","title":"Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects","phase":"","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Aura Biosciences","has_results":false},{"nct_id":"NCT05266430","title":"Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Aura Biosciences","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}